Form 8-K - Current report:
SEC Accession No. 0001144204-06-037721
Filing Date
2006-09-11
Accepted
2006-09-08 19:45:41
Documents
7
Period of Report
2006-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v052360_8k.htm 8-K 534167
2 GRAPHIC locationmap.jpg GRAPHIC 48345
3 GRAPHIC marketsharepiechart.jpg GRAPHIC 19697
4 GRAPHIC productpiechart.jpg GRAPHIC 15908
5 GRAPHIC sharestructurechart4.jpg GRAPHIC 37631
6 v052360_ex99-1.htm EX-99.1 771345
7 v052360_ex99-2.htm EX-99.2 675029
  Complete submission text file 0001144204-06-037721.txt   2151037
Mailing Address 3200 BRISTOL STREET SUITE 710 COSTA MESA CA 92626
Business Address 3200 BRISTOL STREET SUITE 710 COSTA MESA CA 92626 7148662100
RENHUANG PHARMACEUTICALS INC (Filer) CIK: 0000926844 (see all company filings)

EIN.: 881273503 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-24512 | Film No.: 061082872
SIC: 6199 Finance Services